Clinical Trials Logo

Clinical Trial Summary

This will assess whether AFQ056 can have a beneficial effect by reducing cocaine use in Cocaine Use Disorder (CUD) patients as assessed by Timeline Follow-Back cocaine self-report.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03242928
Study type Interventional
Source Novartis
Contact Novartis Pharmaceuticals
Phone +41613241111
Status Recruiting
Phase Phase 2
Start date December 4, 2017
Completion date January 8, 2020

See also
  Status Clinical Trial Phase
Completed NCT00580827 - Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers N/A
Completed NCT01337297 - Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction Phase 1/Phase 2